From BioHealth Investor by H.S. AyoubBioHealthInvestor.com Shares of Biogen Idec Inc. (BIIB) and Genentech, Inc. (DNA) are down in after hours trading on Monday after issuing a letter to physicians and other prescribers regarding…
by Jon C. OggDecember 18, 2006 Biogen Idec Inc. (BIIB) and Genentech, Inc. (DNA) are issuing a DEAR HEALTHCARE PROVIDER letter to physicians and other prescribers, including rheumatologists, neurologists, oncologists, hematologists, dermatologists, nephrologists, oncology…
From Volume Spike Investor Shares of Pain Therapeutics (PTIE) gained almost 8% on Friday as volume spiked more than 5 times the 3-month average daily volume. There were no news releases or other significant…
Picking on people with schizophrenia would seem to be very unfair. If it is a large corporation, the odds against prople with serious mental illness would really seem to be stacked against them. Lawyers…
From BioHealth Investor Things aren’t looking good. I wrote about Encysive Pharmaceuticals (ENCY) on Friday after their stock jumped on news they were restarting a Phase 2 clinical study on TCB3711. My sugestion then…
From BioHealth Investor Biotechnology SHEFFIELD PHARMACTLS +34.33% IMMTECH PHARM INC +19.09% CYTORI THERAPEUTICS +9.96% VERNALIS PLC ADR +9.09% EMERGENT BIOSOLUTION +5.94% Diagnostic Substances EPIX PHARMACEUTICALS +7.11% SYNOVICS PHARMACEUTL +6.25% MONOGRAM BIOSCIENCES +2.96% ORCHID CELLMARK…
From BioHealth Investor Biotechnology PROGEN INDS LTD +119.66% EXACT SCIENCES COR +12.89% ANADYS PHARMACEUTICA +7.29% ADVENTRX PHARMACTL +6.36% SGX PHARMACEUTICALS +5.71% Diagnostic Substances IMMUNOMEDICS INC +3.63% SYNOVICS PHARMACEUTL +3.23% REMOTEMDX INC +3.17% IMMUCELL CP…
From BioHealth Investor Shares of Progen Industries (PGLA) of Australia skyrocketed more than 100% on Wednesday, ending trading at $6.48 a share. The stock price had hit an intraday high of $8.74, a substantial…
From BioHealth Investor by Andrew Vaino As I mentioned last week in the Daily Blog, the patent case between Insmed (INSM) and Tercica (TRCA) was decided in Tercica’s favor. A jury found that Insmed…
At below $70, Amgen (AMGN) trades back where it was in July, 2003, and well below its and well below its September 2005 high of $85. An antitrust claim that was an investor concern…
From BioHealth Investor Biotechnology NUTRITION 21 INC +17.86% HALOZYME THERAPEUTIC +12.74% BIONOVO INC +12.50% DISCOVERY LABS INC +9.61% SENESCO TECH +8.41% Diagnostic Substances VALERA PHARMACEUTICA +45.47% EPIX PHARMACEUTICALS +30.25% NYMOX PHARM CORP +8.31% SYNOVA…
From BioHealth Investor by Mark S. Senak As reported earlier this week, S.3546 – the Dietary and Supplement and Nonprescription Drug Consumer Act was passed by the Senate on December 6. Subsequently, on December…
Stocks: (MRK)(PFE) Merck, along with most Big Pharma, wants to get as far away from the blast of Pfizer’s failed cholesterol drug launch as possible. To that end, MRK announced that it will seek…
Stocks: (PFE)(MRK)(BMY) One of the by-products of the new Democratic controlled Congress is that Big Pharma companies are scared to death. The new Speaker is saying that there should be Medicare legislation to drive…
CryoLife, Inc., (CRY-NYSE) is trading up more than 5% pre-market after it announced that it has received 510(k) marketing approval from the FDA for its ProPatch(TM) Soft Tissue Repair Matrix. ProPatch is used to…